Close Menu

NEW YORK (GenomeWeb) – German genetic testing firm CeGaT said today that it has received €500,000 ($531,615) from the German Federal Ministry of Education and Research to support the development of liquid biopsy methods for the analysis of circulating tumor DNA.

The funding comes from an initiative called the KMU-Innovativ: Biotechnologie-BioChance.

According to CeGaT, the money will help it expand its genetic analysis services to new patients who would currently be ineligible because they cannot safely undergo a tissue biopsy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.